Celgene announces Mark Alles and Jacqualyn Fouse to its Board of Directors

– USA, NJ – Celgene Corporation (NASDAQ:CELG) today announced the election of Mark Alles and Jacqualyn Fouse PhD to its Board of Directors.

Mr. Alles has been with Celgene since 2004, most recently serving as President and Chief Operating Officer (COO). Effective March 1, 2016, Mr. Alles will be promoted to Chief Executive Officer, with Bob Hugin assuming the Executive Chairman role. Before serving as President and COO, Mr. Alles led Celgene’s Hematology and Oncology franchise. Dr. Fouse has been with Celgene since 2010, most recently serving as President of Celgene’s Hematology and Oncology franchise. Effective March 1, 2016, Dr. Fouse will be promoted to President and COO. Before serving as President of Celgene’s Hematology and Oncology franchise, Dr. Fouse served as Celgene’s Chief Financial Officer.

“Mark and Jackie are extremely accomplished leaders who bring a wealth of experience and judgment to our Board,” said Bob Hugin, Chairman and CEO of Celgene Corporation. “Their strategic vision and knowledge of our business will be highly valued as we continue to guide Celgene’s future.”

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>